Tuesday Licensing Forum: Data-Driven Decision-Making for IP Licensing and Transactions
For this week's Tuesday Licensing Forum, on July 25 at 2 p.m. we will have a special presentation and discussion with Mike Perham, CLP, Director for Innovations and External Relations at the Howard Hughes Medical Institute. Please join us for:
Data-Driven Decision-Making for IP Licensing and Transactions: Using the LES Life Sciences Royalty Survey
Abstract:
In 2021 and 2022, the Life Sciences sector of the Licensing Executive Society (LES) USA/Canada collected and analyzed royalty reports covering the prior three years of licensing activity from LES members and stakeholders. The results add to a series of Royalty Rate Surveys, started in 2008, that individually and collectively offer invaluable insights into ordinarily opaque licensing activities of industry, academia, government, and institutional licensing offices. The LES Life Sciences Royalty Rate survey is unique among other publicly available data in that it incorporates early-stage information rather than collecting late-stage deals from SEC filings, and sufficient data is collected and analyzed to offer statistically relevant results. In this session, we will explore the breadth of data available, insights found in that data, and how you can apply it to your own deals.
Tuesday Licensing Forum
Occurs every Tuesday from 2 to 3:30 p.m. ET
Meeting number (access code): 2550 971 1720
Meeting password: P38Ad2DBnQb
About the speaker:
Mike Perham, PhD, CLP, RTTP, is the Director, Innovations and External Relations at the Howard Hughes Medical Institute (HHMI), overseeing technology transfer, open science and external relations. Before HHMI, he handled technology transfer and IP management at The University of Texas Medical Branch (UTMB), the University of Virginia (UVA), a UVA spinoff called ZyGEM/Microlab Diagnostics, and Health Diagnostic Laboratory. He has spent the last 15 years negotiating licenses, managing IP portfolios and open science programs, and leading litigation efforts. Mike is on the leadership of the Licensing Executive Society and led the Life Science Sector Royalty rate survey in 2021 and 2022.